Andhra Pradesh, India

Ranjita Nayak

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ranjita Nayak. Retrieved from https://idiyas.com/inventor/ranjita-nayak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ranjita Nayak: Innovator in Anticancer Research

Introduction

Ranjita Nayak is a notable inventor based in Andhra Pradesh, India. She has made significant contributions to the field of medicinal chemistry, particularly in the development of potential anticancer agents. Her work has the potential to impact cancer treatment positively.

Latest Patents

Ranjita Nayak holds a patent for her invention titled "3-(4-ethylnylphenyl) pyridopyrimidinone compounds and process for preparation thereof useful as potential anticancer agents." This invention provides 3-(4-ethynylphenyl) pyridopyrimidinone compounds of formula A, which have demonstrated promising anticancer activity in sixty human cancer cell lines. The patent highlights her innovative approach to combating cancer through chemical compounds.

Career Highlights

Ranjita Nayak is affiliated with the Council of Scientific and Industrial Research, where she conducts her research. Her dedication to scientific inquiry and innovation has led to her recognition in the field of anticancer research. With 1 patent to her name, she continues to contribute to advancements in cancer treatment.

Collaborations

Some of her coworkers include Ahmed Kamal and Farheen Sultana, who collaborate with her on various research projects. Their teamwork enhances the research output and fosters a productive environment for innovation.

Conclusion

Ranjita Nayak's work in developing anticancer agents showcases her commitment to improving healthcare through innovation. Her contributions are vital in the ongoing fight against cancer, and her research holds promise for future advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…